success survey

Article

Register today on CancerNetwork.com and join our online community of medical professionals. With your free registration you can: - Get unlimited access to news and archives from Oncology and Oncology NEWS International - Receive email newsletters covering the latest oncology news and information - Comment on articles and engage with other healthcare professionals

Register today on CancerNetwork.com and join our online community of medical professionals. With your free registration you can:
- Get unlimited access to news and archives from Oncology and Oncology NEWS International
- Receive email newsletters covering the latest oncology news and information
- Comment on articles and engage with other healthcare professionals

Register now and you'll receive a free online copy of our exclusive book just for physicians - a $20 value!

Achieving Success and Balance
Yes, It Can Be Done. A Physician's Guide to Having It All.

Stressed out? Looking for solutions for efficiency and balance? We can help.
This guide brings you the best of Physicians Practice articles and columns on avoiding burnout and relieving stress, boosting efficiency and increasing revenue, and finding the best way to achieve balance and success.
Click here to register now
 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Despite CD19 CAR T-cell therapy exhibiting efficacy in patients with relapsed/refractory large B-cell lymphoma, less than half achieve long-term remission.
4 experts in this video
4 experts in this video
Related Content